American College of Radiology (ACR)

The American College of Radiology represents diagnostic radiologists, radiation oncologists, interventional radiologists, nuclear medicine physicians and medical physicists. The society represents more than 41,000 diagnostic and interventional radiologists, radiation oncologists, nuclear medicine physicians and medical physicists. ACR helps members, through advocacy, quality and safety, and innovation, and serves as the voice of radiology, demonstrating value and setting standards to advance the field and practice.

ACR has concerns about nonphysician scope creep in radiology
Efforts to expand the scope of practice for these lesser-trained clinicians are increasing as the growing shortage of physicians becomes more pronounced, especially in rural areas.
ACR supports bringing back clinical decision support to combat prior authorizations
Alan Matsumoto, MD, chair of the American College of Radiology, explains ACR support for the Radiology Outpatient Ordering Transmission (ROOT) Act in Congress.
ACR says insurance companies gaming the No Surprises Act with ghost rates
Alan Matsumoto, MD, chair of the American College of Radiology, discusses rad support for a Texas Medical Association lawsuit against the federal government.
ACR says Medicare physician payments are unsustainable, urges congressional action
Alan Matsumoto, MD, chair of the American College of Radiology board, discusses how cuts over the past 20 years have lowered physician payments 33%.
ACR pushes for better explainability of how AI algorithms work
Dana Smetherman, MD, CEO of the American College of Radiology, says the organization wants to see transparent explainability of algorithms to increase public trust.

Dana H. Smetherman, MD, MPH, MBA, FACR, the new CEO of the American College of Radiology (ACR), explains some of the hot button issues in radiology and advocacy efforts led by the ACR.

New ACR CEO outlines key concerns for radiology

Dana Smetherman, MD, MBA, explains some of the hot button issues in imaging and key advocacy efforts being undertaken by the college.

Dana H. Smetherman, MD, MPH, MBA, FACR, the new CEO of the American College of Radiology (ACR), explains with the ongoing 2024 election, it is very unlikely there will be any serious reform to the Medicare payment system this year. She said further Medicare cuts set for 2025 also further threaten patient access to care.

Meaningful Medicare reform unlikely in 2024

New American College of Radiology CEO Dana Smetherman, MD, discusses the impact of reimbursement cuts, issues with staffing costs and prior authorization.

AMA chart showing Medicare update payments compared to the cost of practice inflation between 2001-2024. The ongoing AMA PPI survey will be used top recalculate radiology practice expenses, but only 10 practices so far has submitted data that will impact all radiology practices.

Only 10 radiology practices completed survey used to adjust Medicare payments

The ACR shared its concerns about the lack of participation as the deadline approaches.

ACR presents radiologist with Global Humanitarian Award for African missions

Boyd Hatton, MD, earns the honor for his three years of work with Kilimanjaro Mission Hospital.

ACR updates requirements for on-site staff overseeing contrast administration

A clinician trained to manage reactions should be on-site at any imaging facilities doing contrast studies to maintain patient safety.

ACR earns $100K grant to upgrade lung cancer registry

The college is one of seven groups to receive the grant aimed at improving best practices for lung cancer reporting.

Richard Heller, MD, RSNA Board member, associate chief medical officer for health policy and communications, and national director of pediatric radiology at Radiology Partners, explains some insurance companies are trying to take advantage of the No Surprises Billing Act by telling radiology practices they need to accept lower rates to remain part of the providers in-network.

Radiologists urged to report insurance companies forcing lower reimbursements due to No Surprises Act

Some payers are taking advantage of the NSA by forcing practices to accept lower rates to remain in-network, says Rad Partners' Richard Heller, MD.

The new MRI contrast agent gadopiclenol, sold under the trade names Elucirem and Vueway by Bracco and Guerbet, used 50% less gadolinium that current MRI agents. #RSNA22 #RSNA

New contrast agent earns positive safety classification from ACR

The ACR Committee on Drugs and Contrast Media stated that exposure to the gadolinium-based contrast agent represents a “sufficiently low or possibly nonexistent” risk to patients.

American College of Radiology (ACR)

ACR has concerns about nonphysician scope creep in radiology

ACR supports bringing back clinical decision support to combat prior authorizations

ACR says insurance companies gaming the No Surprises Act with ghost rates

ACR says Medicare physician payments are unsustainable, urges congressional action

ACR pushes for better explainability of how AI algorithms work